Turning Point Therapeutics

-$2.00 (-3.04%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPTX and other ETFs, options, and stocks.

About TPTX

Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor.

CEO
Athena Countouriotis
Employees
142
Headquarters
San Diego, California
Founded
2013

TPTX Key Statistics

Market Cap
3.41B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
387.11K
High Today
$65.84
Low Today
$62.63
Open Price
$65.12
Volume
298.27K
52 Week High
$141.30
52 Week Low
$54.43

TPTX Earnings

-$1.02
-$0.68
-$0.34
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure